1
|
Kayikcioglu M, Tokgozoglu L, Dogan V, Ceyhan C, Tuncez A, Kutlu M, Onrat E, Alici G, Akbulut M, Celik A, Yesilbursa D, Sahin T, Sonmez A, Ozdogan O, Temizhan A, Kilic S, Bayram F, Sabuncu T, Coskun FY, Ildizli M, Durakoglugil E, Kirilmaz B, Yilmaz MB, Yigit Z, Yildirim AB, Gedikli O, Topcu S, Oğuz A, Demir M, Yenerçağ M, Yıldırır A, Demircan S, Yilmaz M, Kaynar LG, Aktan M, Durmus RB, Gokce C, Ozcebe Oİ, Akyol TK, Okutan H, Sag S, Gul OO, Salcioglu Z, Altunkeser BB, Kuku I, Yasar HY, Kurtoglu E, Kose MD, Demircioglu S, Pekkolay Z, Ilhan O, Can LH. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)? Atherosclerosis 2019; 277:341-346. [PMID: 30270069 DOI: 10.1016/j.atherosclerosis.2018.08.012] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/07/2018] [Revised: 07/03/2018] [Accepted: 08/17/2018] [Indexed: 11/28/2022]
Abstract
BACKGROUND AND AIMS Familial hypercholesterolemia (FH) is a common genetic disease of high-level cholesterol leading to premature atherosclerosis. One of the key aspects to overcome FH burden is the generation of large-scale reliable data in terms of registries. This manuscript underlines the important results of nation-wide Turkish FH registries (A-HIT1 and A-HIT2). METHODS A-HIT1 is a survey of homozygous FH patients undergoing low density lipoprotein (LDL) apheresis (LA). A-HIT2 is a registry of adult FH patients (homozygous and heterozygous) admitted to outpatient clinics. Both registries used clinical diagnosis of FH. RESULTS A-HIT1 evaluated 88 patients (27 ± 11 years, 41 women) in 19 centers. All patients were receiving regular LA. There was a 7.37 ± 7.1-year delay between diagnosis and initiation of LA. LDL-cholesterol levels reached the target only in 5 cases. Mean frequency of apheresis sessions was 19 ± 13 days. None of the centers had a standardized approach for LA. Mean frequency of apheresis sessions was every 19 ± 13 (7-90) days. Only 2 centers were aware of the target LDL levels. A-HIT2 enrolled 1071 FH patients (53 ± 8 years, 606 women) from 31 outpatients clinics specialized in cardiology (27), internal medicine (1), and endocrinology (3); 96.4% were heterozygous. 459 patients were on statin treatment. LDL targets were attained in 23 patients (2.1% of the whole population, 5% receiving statin) on treatment. However, 66% of statin-receiving patients were on intense doses of statins. Awareness of FH was 9.5% in the whole patient population. CONCLUSIONS The first nationwide FH registries revealed that FH is still undertreated even in specialized centers in Turkey. Additional effective treatment regiments are urgently needed.
Collapse
Affiliation(s)
| | | | - Volkan Dogan
- Mugla Sitki Kocman Univ Faculty of Med, Mugla, Turkey
| | | | | | - Merih Kutlu
- Karadeniz Teknik Univ Faculty of Med, Trabzon, Turkey
| | | | - Gokhan Alici
- Kartal Kosuyolu Res & Training Hosp, Istanbul, Turkey
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Zerrin Yigit
- Istanbul University Cardiology Institute, Istanbul, Turkey
| | | | | | - Selim Topcu
- Ataturk Univ Faculty of Med, Erzurum, Turkey
| | | | | | | | | | | | | | | | - Melih Aktan
- Istanbul University Istanbul Univ Faculty of Med, Istanbul, Turkey
| | | | | | | | | | - Harika Okutan
- Diskapi Yildirim Beyazit Res & Training Hosp, Ankara, Turkey
| | - Saim Sag
- Uludag Univ Faculty of Med, Bursa, Turkey
| | | | - Zafer Salcioglu
- Kanuni Sultan Suleyman Res & Training Hosp, Istanbul, Turkey
| | | | - Irfan Kuku
- Inonu Univ Faculty of Med, Malatya, Turkey
| | | | | | | | | | | | | | | |
Collapse
|
2
|
Kayikcioglu M, Kuman-Tunçel O, Pirildar S, Yílmaz M, Kaynar L, Aktan M, Durmuş RB, Gökçe C, Temizhan A, Özcebe OI, Akyol TK, Okutan H, Sağ S, Oz Gul O, Salcioglu Z, Yenercag M, Altunkeser BB, Kuku I, Yasar HY, Kurtoğlu E, Demir M, Demircioğlu S, Pekkolay Z, Ílhan O, Tokgozoglu L. Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry). J Clin Lipidol 2019; 13:455-467. [DOI: 10.1016/j.jacl.2019.02.001] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2018] [Revised: 01/24/2019] [Accepted: 02/01/2019] [Indexed: 01/18/2023]
|
3
|
Onec B, Okutan H, Albayrak M, Can ES, Aslan V, Koluman BU, Kosemehmetoglu OS, Albayrak A. Combination therapy with azacitidine, etoposide, and cytarabine in the treatment of elderly acute myeloid leukemia patients: A single center experience. J Cancer Res Ther 2018; 14:1105-1111. [PMID: 30197357 DOI: 10.4103/0973-1482.187369] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Aims The prognosis of acute myeloid leukemia (AML) in elderly patients is worse due to age and comorbidities. Lately, monotherapy with hypomethylating agents like azacitidine (Aza) has been used to prolong overall survival (OS) in AML patients. Herein, we present a retrospective study investigating treatment responses and OS of Aza in combination with etoposide (Eto) and cytarabine (ARA-C) in elderly. Materials and Methods In this study, therapies and outcomes of 37 newly diagnosed AML patients, >60 years old, and ineligible for intensive chemotherapy were investigated retrospectively. Patients were grouped according to the treatments they received as follows - Group 1: low-dose conventional therapies as hydroxyurea, low-dose ARA-C, or best supportive care (n = 11); Group 2: Aza alone (n = 6); Group 3: Aza in combination with Eto and ARA-C (Aza + Eto + ARA-C, n = 20). Results It was found that an Aza + Eto + ARA-C combination therapy had significantly better overall response rates (P = 0.002). Combination group had significantly better OS than Group 1 (8 months vs. 1 month, P < 0.001), the difference between combination and monotherapy was not significant. The OS was also associated with age and performance status, but the difference was still statistically significant after adjustment for these factors, especially for patients with younger age and better performance. Conclusions We concluded that combination therapy of Aza with Eto and ARA-C increases response rates, and prolong survival for this poor prognosed patient group. We believe that larger controlled studies investigating Aza combinations with other antileukemic drugs will contribute to the development of tolerable treatment protocols for elderly AML patients.
Collapse
Affiliation(s)
- Birgul Onec
- Department of Hematology, Ankara Diskapi Yıldırım Beyazit Training and Research Hospital, Ankara, Turkey
| | - Harika Okutan
- Department of Hematology, Ankara Diskapi Yıldırım Beyazit Training and Research Hospital, Ankara, Turkey
| | - Murat Albayrak
- Department of Hematology, Ankara Diskapi Yıldırım Beyazit Training and Research Hospital, Ankara, Turkey
| | - Esra Saribacak Can
- Department of Hematology, Ankara Diskapi Yıldırım Beyazit Training and Research Hospital, Ankara, Turkey
| | - Vedat Aslan
- Department of Hematology, Ankara Diskapi Yıldırım Beyazit Training and Research Hospital, Ankara, Turkey
| | - Basak Unver Koluman
- Department of Hematology, Ankara Diskapi Yıldırım Beyazit Training and Research Hospital, Ankara, Turkey
| | - Ozge Soyer Kosemehmetoglu
- Department of Hematology, Ankara Diskapi Yıldırım Beyazit Training and Research Hospital, Ankara, Turkey
| | - Aynur Albayrak
- Department of Pathology, Ankara Diskapi Yıldırım Beyazit Training and Research Hospital, Ankara, Turkey
| |
Collapse
|
4
|
Tahtaci M, Yildiz N, Okutan H, Kuyucu Yildiz S. Nerve excitability in iron deficiency anemia: a prospective study. NEUROL SCI NEUROPHYS 2018. [DOI: 10.5152/nsn.2018.11095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
5
|
Yıldız A, Albayrak M, Pala Ç, Şahin O, Afacan Öztürk HB, Güneş G, Maral S, Okutan H. Infections in patients with lymphoma: An analysis of incidence, relationship and risk factors. J Infect Dev Ctries 2018; 12:741-747. [PMID: 31999632 DOI: 10.3855/jidc.10399] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2018] [Accepted: 08/05/2018] [Indexed: 10/31/2022] Open
Abstract
INTRODUCTION Bacterial infections and febrile neutropenia (FN) are major causes of morbidity and mortality in patients with hematological malignancy. The aim of this study was to investigate the incidence and risk factors of infections in lymphoma patients. METHODOLOGY This retrospective study was conducted on 200 lymphoma patients diagnosed and treated between January 2009 and December 2017 in Diskapi Yildirim Beyazit Training and Research Hospital, a tertiary referral hospital in Ankara, Turkey. RESULTS The mean follow-up period was 20.09 ± 19.81 months. The incidence of infection episode (IE) was 32.5% (65/200) and FN was 18.5% (37/200). Analysis of the data revealed that patients with IE had significantly higher rates of diagnosis of primary central nervous system lymphoma (PCNSL), lower baseline hemoglobin, lower baseline hematocrit, higher baseline lactate dehydrogenase levels, higher usage of central cathater, and a higher number of chemotherapy lines compared to patients with no IE. In logistic regression analysis, disease subtype of PCNSL, usage of central catheter and lactate deyhydrogenase (LDH) were found to increase the risk of infection. The odds ratio for PCNSL was 37.866 (p = 0.003), 2.679 for central catheter (p = 0.008) and 1.001 for LDH (p = 0.011). CONCLUSIONS The risk of infection in patients with lymphoma was associated with central catheter usage, higher LDH levels and a diagnosis of PCNSL. Baseline hematological parameters were not determined to have any impact on the occurrence of infection. Patients with these risk factors should be monitored more carefully and the maximum level of infection prevention should be taken.
Collapse
Affiliation(s)
- Abdulkerim Yıldız
- Diskapi Yildirim Beyazit Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
| | - Murat Albayrak
- Diskapi Yildirim Beyazit Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
| | - Çiğdem Pala
- Diskapi Yildirim Beyazit Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
| | - Osman Şahin
- Diskapi Yildirim Beyazit Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
| | - Hacer Berna Afacan Öztürk
- Diskapi Yildirim Beyazit Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
| | - Gürsel Güneş
- Diskapi Yildirim Beyazit Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
| | - Senem Maral
- Diskapi Yildirim Beyazit Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
| | - Harika Okutan
- Lösante's Children and Adult Hospital, Ankara, Turkey.
| |
Collapse
|
6
|
Yıldız A, Öztürk HBA, Albayrak M, Pala Ç, Şahin O, Maral S, Okutan H. Is antimicrobial prophylaxis necessary for lymphoma patients? A single centre, real-life experience. J Oncol Pharm Pract 2018; 25:1381-1387. [DOI: 10.1177/1078155218795323] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Background Prophylaxis is strongly recommended in patients with hematological malignancy who are usually at higher risk for infection and neutropenic fever. It is still unclear whether or not there is a definite need for antimicrobial prophylaxis in intermediate-risk hematology patients such as those with lymphoma. Methods A retrospective analysis was made of patients admitted from January 2009 to December 2017 to the Hematology Department of Diskapi Yildirim Beyazit Training and Research Hospital, a tertiary referral hospital in Ankara, Turkey. The study included patients who were diagnosed with any type of lymphoma and given chemotherapy. Routine antimicrobial prophylaxis was administered to 127 lymphoma patients, and not to 65 lymphoma patients. These two groups were compared in respect of the incidence of total infection episodes (IE), febrile neutropenia episodes, and nonneutropenic clinically documented infection episodes. Results For all patients with lymphoma and subtypes of non-Hodgkin lymphoma or Hodgkin lymphoma, no significant difference was determined between the groups in respect of the total incidence of IE, febrile neutropenia and nonneutropenic clinically documented infection both during the first-line chemotherapy and throughout the total follow-up period ( p > 0.05). Patients with prophylaxis had a higher incidence of IE, which was treated with parenteral antibiotics both during the first-line chemotherapy and throughout the total follow-up period ( p < 0.05). Conclusion Antimicrobial prophylaxis was seen to have no effect on the total incidence of infection episode and febrile neutropenia. Therefore, the routine use of antimicrobial prophylaxis should not be recommended for patients with lymphoma.
Collapse
Affiliation(s)
- Abdulkerim Yıldız
- Department of Hematology, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey
| | - Hacer BA Öztürk
- Department of Hematology, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey
| | - Murat Albayrak
- Department of Hematology, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey
| | - Çiğdem Pala
- Department of Hematology, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey
| | - Osman Şahin
- Department of Hematology, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey
| | - Senem Maral
- Department of Hematology, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey
| | - Harika Okutan
- Department of Adult Hematology, Lösante's Children and Adult Hospital, Ankara, Turkey
| |
Collapse
|
7
|
Karaca C, Sözen S, Orhon D, Okutan H. High temperature pyrolysis of sewage sludge as a sustainable process for energy recovery. Waste Manag 2018; 78:217-226. [PMID: 32559907 DOI: 10.1016/j.wasman.2018.05.034] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/08/2017] [Revised: 05/14/2018] [Accepted: 05/18/2018] [Indexed: 06/11/2023]
Abstract
This study explored the potential of high temperature pyrolysis for energy recovery from domestic sewage. It mainly defines optimum operating conditions to maximize syngas generation. A pyrolysis unit was operated in batch mode, at temperatures of 450, 600 and 850 °C, rotation speeds of 10, 40 and 60 Hz. The sludge had 6% moisture content; it contained 65% organic matter and involved a low calorific value of 13.535 kJ/kg dry matter. Pyrolysis at 850 °C and high rotation speed of 60 Hz yielded the highest conversion of sludge to syngas, with an average of 59% of the organic matter as syngas, 29% as tar and 12% as biochar. Pyrolysis enabled 74% of the energy recovery as syngas and tar. Continuous full-scale pyrolysis systems would further increase the syngas by recovering condensable gaseous products and/or recycling tar back into the pyrolysis unit. A unified approach for energy recovery management should equally consider what fraction of the energy contained in the wastewater was consumed and wasted before generating the sludge. Therefore, the adopted management scheme should also cover all design and operation parameters of the treatment plant, because this is how the energy is best conserved even before the sludge is generated.
Collapse
Affiliation(s)
- C Karaca
- ENVIS Energy and Environmental Systems R&D Ltd, ITU Arı Teknokent, Arı-1 Building No. 16, 34469 Maslak, Istanbul, Turkey
| | - S Sözen
- ENVIS Energy and Environmental Systems R&D Ltd, ITU Arı Teknokent, Arı-1 Building No. 16, 34469 Maslak, Istanbul, Turkey; Faculty of Civil Engineering, Environmental Engineering Department, Istanbul Technical University, 34469 Maslak, Istanbul, Turkey.
| | - D Orhon
- ENVIS Energy and Environmental Systems R&D Ltd, ITU Arı Teknokent, Arı-1 Building No. 16, 34469 Maslak, Istanbul, Turkey; Civil Engineering Department, Near East University, Nicosia, North Cyprus
| | - H Okutan
- Faculty of Chemical and Metallurgical Engineering, Chemical Engineering Processing Department, Istanbul Technical University, 34469 Maslak, Istanbul, Turkey
| |
Collapse
|
8
|
Yıldız A, Şahin O, Yayar O, Öztürk ÇP, Afacan Öztürk HB, Maral S, Okutan H, Albayrak M. The rare coexistence of high titer inhibitor development and gastrointestinal stromal tumor in a patient with severe hemophilia: A case report. Transfus Apher Sci 2018; 57:398-400. [DOI: 10.1016/j.transci.2018.04.023] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2018] [Revised: 04/17/2018] [Accepted: 04/24/2018] [Indexed: 01/20/2023]
|
9
|
Sarıbacak Can E, Okutan H, Albayrak M, Han Ü. Extranodal Natural Killer/T-Cell Lymphoma: A Rare Nasal-Type Case. Turk J Haematol 2017; 33:74-5. [PMID: 27020724 PMCID: PMC4805345 DOI: 10.4274/tjh.2015.0169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Affiliation(s)
- Esra Sarıbacak Can
- Dışkapı Yıldırım Beyazıt Research and Training Hospital, Clinic of Hematology, Ankara, Turkey. E-mail:
| | | | | | | |
Collapse
|
10
|
Onec B, Okutan H, Albayrak M, Can ES, Aslan V, Soyer Kosemehmetoglu O, Unver Koluman B. Comparative Evaluation of Common Comorbidity Scores and Freiburger Comorbidity Index as Prognostic Variables in a Real Life Multiple Myeloma Population. Indian J Hematol Blood Transfus 2016; 32:424-430. [PMID: 27812251 DOI: 10.1007/s12288-015-0618-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2015] [Accepted: 11/05/2015] [Indexed: 11/26/2022] Open
Abstract
Multiple myeloma (MM) is a disease of the geriatric population with a median age at diagnosis of 69 years but most clinicians consider performance status and comorbidities rather than chronological age in determining prognosis and treatment. The purpose of this study was to assess whether and which comorbidity indices predict survival in a real life population of MM. We calculated Charlson Comorbidity Index (CCI), age combined Charlson index (CCI-age), Hematopoietic cell transplantation-specific comorbidity index (HCT-SCI) and Freiburger comorbidity index (FCI) retrospectively for 66 MM patients and compared their impact on treatment responses and overall survival (OS). Treatment response was significantly worse in groups with high CCI, CCI-age, HCT-SCI scales (p < 0.05), but FCI's effect on treatment response was not significant. However, while no significant relationship was determined between other comorbidity indices with OS, it was related only with FCI-CI (p = 0.006). FCI, developed in this patient group, was the only prognostic index with a significant effect on OS in the evaluation of comorbidities in MM patients with different scores, but its relationship to treatment responses was not significant contrary to other indices. While this small patient group gave us hope regarding the use of FCI in practice, multi-center studies are still required.
Collapse
Affiliation(s)
- Birgul Onec
- Department of Hematology, Duzce University Faculty of Medicine, 81000 Konuralp, Duzce Turkey ; Department of Hematology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey
| | - Harika Okutan
- Department of Hematology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey
| | - Murat Albayrak
- Department of Hematology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey
| | - Esra Sarıbacak Can
- Department of Hematology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey
| | - Vedat Aslan
- Department of Hematology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey
| | | | - Basak Unver Koluman
- Department of Hematology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey
| |
Collapse
|
11
|
Onec B, Okutan H, Albayrak M, Saribacak Can E, Aslan V, Unver Koluman B, Soyer Kosemehmetoglu O, Albayrak A, Kos DM. The Predictive Role of the Neutrophil/Lymphocyte Ratio in Survival with Multiple Myeloma: A Single Center Experience. J Clin Lab Anal 2016; 31. [PMID: 27500465 DOI: 10.1002/jcla.22032] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2016] [Accepted: 07/01/2016] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND Recent studies have shown a positive correlation between tumor-related immune response markers and the poor outcome in solid tumors. In this study, we aimed to investigate the neutrophil/lymphocyte ratio (NLR) in multiple myeloma. To the best of our knowledge, this would be the second report concerning this topic. METHODS We retrospectively reviewed the data for 52 multiple myeloma patients. The patients were grouped using the baseline NLR as NLR ≤ 1.72 and NLR > 1.72 using receiver operating characteristic analysis to determine a cut off. We compared the two groups in terms of both the known prognostic factors of the myeloma and the overall survival (OS). RESULTS Our study showed that NLR is associated with C-reactive protein and β2 microglobulin (P = 0.02 and P = 0.001, respectively). The patients with NLR > 1.72 had significantly worse stages, performance status, and kidney functions. The whole group's OS was estimated as 35.1 months while the patients with lower NLR had better OS when compared with those with NLR > 1.72 (42.75 and 26.14 months, respectively, P: 0.04). CONCLUSION Neutrophil/lymphocyte ratio, which is associated with stage, performance status, and kidney functions, can be used in daily practice as a predictor for survival in multiple myeloma. Simply adding NLR to the routine charts may enrich our data for larger studies.
Collapse
Affiliation(s)
- Birgul Onec
- Department of Hematology, Dışkapı Training and Research Hospital, Ankara, Turkey
| | - Harika Okutan
- Department of Hematology, Dışkapı Training and Research Hospital, Ankara, Turkey
| | - Murat Albayrak
- Department of Hematology, Dışkapı Training and Research Hospital, Ankara, Turkey
| | - Esra Saribacak Can
- Department of Hematology, Dışkapı Training and Research Hospital, Ankara, Turkey
| | - Vedat Aslan
- Department of Hematology, Dışkapı Training and Research Hospital, Ankara, Turkey
| | - Basak Unver Koluman
- Department of Hematology, Dışkapı Training and Research Hospital, Ankara, Turkey
| | | | - Aynur Albayrak
- Department of Pathology, Dışkapı Training and Research Hospital, Ankara, Turkey
| | - Durdu Mehmet Kos
- Department of Internal Medicine, Faculty of Medicine, Düzce University, Düzce, Turkey
| |
Collapse
|
12
|
Basturk A, Akinci S, Hacibekiroglu T, Guney T, Kutlucan A, Ceran F, Akalin SD, Ozturk SMB, Okutan H, Ozet G, Dilek I. Prognostic significance of flow cytometry findings in Turkish adult acute leukemia patients. Eur Rev Med Pharmacol Sci 2015; 19:3360-3366. [PMID: 26439029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
OBJECTIVE Several factors are known to affect prognosis of acute leukemia such as age, high leukocyte count, cytogenetic abnormality, performance status and recurrent leukemia. We aimed to investigate the association between cell surface markers and prognostic determinants such as recurrence at 6 and 12 months and survival at 6, 12 and 18 months in acute leukemia patients. PATIENTS AND METHODS A total of 142 patients, 101 with acute myeloid leukemia (AML) and 41 with B-cell acute lymphoblastic leukemia (B-ALL) were included. The effects of surface markers on survival and recurrence rates were evaluated retrospectively. RESULTS In AML patients, CD5+ and CD34+ immunophenotypes and in ALL patients cCD22+, CD34+ and CD49f + CD19+ immunophenotypes were positive prognostic indicators. In AML patients CD7 expression, and in ALL patients CD5+, CD7+ and CD117+ immunophenotypes and >90% CD45 expression were negative prognostic indicators. CONCLUSIONS This study demonstrates that flow cytometry, a common diagnostic tool in acute leukemia, may also have prognostic value in acute leukemia in the future.
Collapse
Affiliation(s)
- A Basturk
- Division of Hematology, Department of Internal Medicine, Konya Research and Training Hospital, Konya, Turkey.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Tekin S, Zengin M, Tekin İ, Yucetin L, Yavuz H, Okutan H, Demirbas A. Simultaneous Cardiac Surgery and Renal Transplantation Compared With Renal Transplantation After Cardiac Surgery. Transplant Proc 2015; 47:1340-4. [DOI: 10.1016/j.transproceed.2015.04.024] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
14
|
Koluman BÜ, Albayrak M, Okutan H. A rare combination: Combined factor V and factor VIII deficiency. J Clin Exp Invest 2014. [DOI: 10.5799/ahinjs.01.2014.02.0413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
15
|
Tekin İ, Toprak E, Kapan Ş, Okutan H. OP-005 PERCUTANEOUS ULTRASOUND ACCELERATED THROMBOLYSIS IS AN EFFECTIVE TREATMENT MODALITY FOR ACUTE PULMONARY THROMBOEMBOLIC EVENTS: CASE REPORT. Int J Cardiol 2013. [DOI: 10.1016/s0167-5273(13)70006-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
16
|
Ozaydin M, Icli A, Yucel H, Akcay S, Peker O, Erdogan D, Varol E, Dogan A, Okutan H. Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study. Eur Heart J 2013; 34:597-604. [DOI: 10.1093/eurheartj/ehs423] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 08/30/2023] Open
|
17
|
Gülmen S, Kurtoglu T, Doguç D, Meteoglu I, Kocyigit A, Okutan H. PP-430 THE EFFECT OF OZONE PRECONDITIONING ON RENAL ISCHEMIA-REPERFUSION INJURY INDUCED BY TRANSIENT AORTIC OCCLUSION IN RATS. Int J Cardiol 2012. [DOI: 10.1016/s0167-5273(12)70548-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
18
|
Rowland FS, Blake DR, Larsen BR, Lindskog A, Peterson PJ, Williams WP, Wallington TJ, Pilling MJ, Carslaw N, Creasey DJ, Heard DE, Jacobs P, Lee J, Lewis AC, McQuaid JB, Stockwell WR, Frank H, Sacco P, Cocheo V, Lynge E, Andersen A, Nilsson R, Barlow L, Pukkala E, Nordlinder R, Boffetta P, Grandjean P, Heikkil P, Hürte LG, Jakobsson R, Lundberg I, Moen B, Partanen T, Riise T, Borowiak A, De Saeger E, Schnitzler KG, Gravenhorst G, Jacobi HW, Moelders S, Lammel G, Busch G, Beese FO, Dentener FJ, Feichter J, Fraedrich K, Roelofs GJ, Friedrich R, Reis S, Voehringer F, Simpson D, Moussiopoulos N, Sahm P, Tourlou PM, Salmons R, Papameletiou D, Maqueda JM, Suhr PB, Bell W, Paton-Walsh C, Woods PT, Partridge RH, Slemr J, Slemr F, Schmidbauer N, Ravishankara AR, Jenkin ME, de Leeuw G, van Eijk AM, Flossmann AI, Wobrock W, Mestayer PG, Tranchant B, Ljungström E, Karlsson R, Larsen SE, Roemer M, Builtjes PJ, Koffi B, Koffi EN, De Saeger E, Ro-Poulsen H, Mikkelsen TN, Hummelshøj P, Hovmand MF, Simoneit BR, van der Meulen A, Meyer MB, Berndt T, Böge O, Stratmann F, Cass GR, Harrison RM, Shi JP, Hoffmann T, Warscheid B, Bandur R, Marggraf U, Nigge W, Kamens R, Jang M, Strommen M, Chien CJ, Leach K, Ammann M, Kalberer M, Arens F, Lavanchy V, Gâggeler HW, Baltensperger U, Davies JA, Cox RA, Alonso SG, Pastor RP, Argüello GA, Willner H, Berndt T, Böge O, Bogillo VI, Pokrovskiy VA, Kuraev OV, Gozhyk PF, Bolzacchini E, Bruschi M, Fantucci P, Meinardi S, Orlandi M, Rindone B, Bolzacchini E, Bohn B, Rindone B, Bruschi M, Zetzsch C, Brussol C, Duane M, Larsen B, Carlier P, Kotzias D, Caracena AB, Aznar AM, Ferradás EG, Christensen CS, Skov H, Hummelshøj P, Jensen NO, Lohse C, Cocheo V, Sacco P, Chatzis C, Cocheo V, Sacco P, Boaretto C, Quaglio F, Zaratin L, Pagani D, Cocheo L, Cocheo V, Asnar AM, Baldan A, Ballesta PP, Boaretto C, Caracena AB, Ferradas EG, Gonzalez-Flesca N, Goelen E, Hansen AB, Sacco P, De Saeger E, Skov H, Consonni V, Gramatica P, Santagostino A, Galvani P, Bolzacchini E, Consonni V, Gramatica P, Todeschini R, Dippel G, Reinhardt H, Zellner R, Dämmer K, Bednarek G, Breil M, Zellner R, Febo A, Allegrini I, Giliberti C, Perrino C, Fogg PG, Geiger H, Barnes I, Becker KH, Maurer T, Geyskens F, Bormans R, Lambrechts M, Goelen E, Giese M, Frank H, Glasius M, Hornung P, Jacobsen JK, Klausen HS, Klitgaard KC, Møller CK, Petersen AP, Petersen LS, Wessel S, Hansen TS, Lohse C, Boaretto E, Heinemeier J, Glasius M, Di Bella D, Lahaniati M, Calogirou A, Jensen NR, Hjorth J, Kotzias D, Larsen BR, Gonzalez-Flesca N, Cicolella A, Bates M, Bastin E, Gurbanov MA, Akhmedly KM, Balayev VS, Haselmann KF, Ketola R, Laturnus F, Lauritsen FR, Grøn C, Herrmann H, Ervens B, Reese A, Umschlag T, Wicktor F, Zellner R, Herrmann H, Umschlag T, Müller K, Bolzacchini E, Meinardi S, Rindone B, Jenkin ME, Hayman GD, Jensen NO, Courtney M, Hummelshøj P, Christensen CS, Larsen BR, Johnson MS, Hegelund F, Nelander B, Kirchner F, Klotz B, Barnes I, Sørensen S, Becker KH, Etzkorn T, Platt U, Wirtz K, Martín-Reviejo M, Laturnus F, Martinez E, Cabañas B, Aranda A, Martín P, Salgado S, Rodriguez D, Masclet P, Jaffrezo JL, Hillamo R, Mellouki A, Le Calvé S, Le Bras G, Moriarty J, O'Donnell S, Wenger J, Sidebottom H, Mingarrol MT, Cosin S, Pastor RP, Alonso SG, Sanz MJ, Bravo I, Gonzalez D, Pérez MA, Mustafaev I, Mammadova S, Noda J, Hallquist M, Langer S, Ljungström E, Nohara K, Kutsuna S, Ibusuki T, Oehme M, Kölliker S, Brombacher S, Merz L, Pastor RP, Alonso SG, Cabezas AQ, Peeters J, Vereecken L, El Yazal J, Pfeffer HU, Breuer L, Platz J, Nielsen OJ, Sehested J, Wallington TJ, Ball JC, Hurley MD, Straccia AM, Schneider WF, Pérez-Casany MP, Nebot-Gil I, Sánchez-Marín J, Putz E, Folberth G, Pfister G, Weissflog L, Elansky NP, Sørensen S, Barnes I, Becker KH, Shao M, Heiden AC, Kley D, Rockel P, Wildt J, Silva GV, Vasconcelos MT, Fernandes EO, Santos AM, Skov H, Hansen A, Løfstrøm P, Lorenzen G, Stabel JR, Wolkoff P, Pedersen T, Strom AB, Skov H, Hertel O, Jensen FP, Hjorth J, Galle B, Wallin S, Theloke J, Libuda HG, Zabel F, Touaty M, Bonsang B, Ullerstam M, Langer S, Ljungström E, Wenger J, Bonard A, Manning M, Nolan S, O'Sullivan N, Sidebottom H, Wenger J, Collins E, Moriarty J, O'Donnell S, Sidebottom H, Wenger J, Collins E, Moriarty J, O'Donnell S, Sidebottom H, Wenger J, Sidebottom H, Chadwick P, O'Leary B, Treacy J, Wolkoff P, Clausen PA, Wilkins CK, Hougaard KS, Nielsen GD, Zilinskis V, Jansons G, Peksens A, Lazdins A, Arinci YV, Erdöl N, Ekinci E, Okutan H, Manlafalioglu I, Bakeas EB, Siskos PA, Viras LG, Smirnioudi VN, Bottenheim JW, Biesenthal T, Gong W, Makar P, Delmas V, Menard T, Tatry V, Moussafir J, Thomas D, Coppalle A, Ellermann T, Hertel O, Skov H, Frohn L, Manscher OH, Friis J, Girgzdiene R, Girgzdys A, Gurevich NA, Gårdfeldt K, Langer S, Hermans C, Vandaele AC, Carleer M, Fally S, Colin R, Bernath PF, Jenouvrier A, Coquart B, Mérienne MF, Hertel O, Frohn L, Skov H, Ellermann T, Huntrieser H, Schlager H, Feigl C, Kemp K, Palmgren F, Kiilsholm S, Rasmussen A, Sørensen JH, Klemm O, Lange H, Larsen RW, Larsen NW, Nicolaisen F, Sørensen GO, Beukes JA, Larsen PB, Jensen SS, Fenger J, de Leeuw G, Kunz G, Cohen L, Schlünzen H, Muller F, Schulz M, Tamm S, Geernaert G, Hertel O, Pedersen B, Geernaert LL, Lund S, Vignati E, Jickells T, Spokes L, Matei C, Jinga OA, Jinga DC, Moliner R, Braekman-Danheux C, Fontana A, Suelves I, Thieman T, Vassilev S, Skov H, Hertel O, Zlatev Z, Brandt J, Bastrup-Birk A, Ellermann T, Frohn L, Vandaele AC, Hermans C, Carleer M, Tsouli A, Colin R, Windsperger AM, Turi K, Dworak O, Zellweger C, Weingartner E, Rüttimann R, Hofer P, Baltensperger U, Ziv A, Iakovleva E, Palmgren F, Berkovicz R, Skov H, Alastuey A, Querol X, Chaves A, Lopez-Soler A, Ruiz C, Andrees JM, Allegrini I, Febo A, Giusto M, Angeloni M, Di Filippo P, D'Innocenzio F, Lepore L, Marconi A, Arshinov MY, Belan BD, Davydov DK, Kovaleskii VK, Plotinov AP, Pokrovskii EV, Sklyadneva TK, Tolmachev GN, Arshinov MY, Belan BD, Sklyadneva TK, Behnke W, Elend M, Krüger U, Zetzsch C, Belan BD, Arshinov MY, Davydov DK, Kovalevskii VK, Plotnikov AP, Pokrovskii EV, Rasskazchikova TM, Sklyadneva TK, Tolmachev GN, Belan BD, Arshinov MY, Simonenkov DV, Tolmachev GN, Bilde M, Aker PM, Börensen C, Kirchner U, Scheer V, Vogt R, Ellermann T, Geernaert LL, Pryor SC, Barthelmie RJ, Feilberg A, Nielsen T, Kamens RM, Freitas MC, Marques AP, Reis MA, Alves LC, Ilyinskikh NN, Ilyinskikh IN, Ilyinskikh EN, Johansen K, Stavnsbjerg P, Gabrielsson P, Bak F, Andersen E, Autrup H, Kamens R, Jang M, Strommen M, Leach K, Kirchner U, Scheer V, Börensen C, Vogt R, Igor K, Svjatoslav G, Anatoliy B, Komov IL, Istchenko AA, Lourenço MG, Mactavish D, Sirois A, Masclet P, Jaffrezo JL, van der Meulen A, Milukaite A, Morkunas V, Jurgutis P, Mikelinskiene A, Nielsen T, Feilberg A, Binderup ML, Pineda M, Palacios JM, Garcia E, Cilleruelo C, Moliner R, Popovitcheva OB, Trukhin ME, Persiantseva NM, Buriko Y, Starik AM, Demirdjian B, Suzanne J, Probst TU, Rietz B, Alfassi ZB, Pokrovskiy VA, Zenobi R, Bogatyr'ov VM, Gun'ko VM, Querol X, Alastuey A, Lopez-Soler A, Mantilla E, Plana F, Artiño B, Rauterberg-Wulff A, Israël GW, Rocha TA, Duarte AC, Röhrl A, Lammel G, Spindler G, Müller K, Herrmann H, Strommen MR, Vignati E, de Leeuw G, Berkowicz R. Abstracts of the 6th FECS Conference 1998 Lectures. Environ Sci Pollut Res Int 1998; 5:119-96. [PMID: 19002640 DOI: 10.1007/bf02986409] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Affiliation(s)
- F S Rowland
- Department of Chemistry, University of California, Irvine, 92697, California, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|